当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析

联环药业

(600513)

  

流通市值:40.62亿  总市值:40.62亿
流通股本:2.85亿   总股本:2.85亿

联环药业(600513)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.07亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益168775.01万元,未分配利润62787.57万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产415649.92万元,负债246874.91万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入810,625,785.822,711,858,051.352,082,459,109.351,285,342,346.98
营业总成本800,833,222.392,711,961,483.082,028,444,912.551,230,280,455.15
其他经营收益
营业利润10,983,083.37-10,398,904.659,458,501.6953,247,534.36
利润总额10,600,496.5-87,605,668.22-1,497,221.37-7,505,817.9
净利润7,362,385.18-84,152,794.56-27,722,396.42-32,357,597.04
每股收益
其他综合收益634,095.24-124,595.73-104,216.08-96,708.4
综合收益总额7,996,480.42-84,277,390.29-27,826,612.5-32,454,305.44
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,980,727,005.811,986,128,036.842,071,311,398.651,823,669,253.17
非流动资产:
非流动资产合计2,175,772,209.662,110,688,108.492,037,884,083.421,930,497,163.23
资产总计4,156,499,215.474,096,816,145.334,109,195,482.073,754,166,416.4
流动负债:
流动负债合计2,116,220,267.932,028,633,157.421,818,122,785.81,550,209,214.05
非流动负债:
非流动负债合计352,528,861.92388,429,382.71553,839,851.43510,762,647.23
负债合计2,468,749,129.852,417,062,540.132,371,962,637.232,060,971,861.28
所有者权益(或股东权益):
归属于母公司股东权益合计1,278,805,740.091,271,746,892.761,335,037,578.71,330,078,873.04
股东权益合计1,687,750,085.621,679,753,605.21,737,232,844.841,693,194,555.12
负债和股东权益合计4,156,499,215.474,096,816,145.334,109,195,482.073,754,166,416.4
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计708,721,708.42,941,689,418.212,081,145,862.631,297,002,897.03
经营活动现金流出小计787,676,209.782,956,159,501.822,254,027,017.881,454,812,510.03
经营活动产生的现金流量净额-78,954,501.38-14,470,083.61-172,881,155.25-157,809,613
投资活动产生的现金流量:
投资活动现金流入小计-5,695,423.516,4686,468
投资活动现金流出小计59,913,763.79491,696,435.37292,776,850.53206,284,153.28
投资活动产生的现金流量净额-59,913,763.79-486,001,011.87-292,760,382.53-206,277,685.28
筹资活动产生的现金流量:
筹资活动现金流入小计374,109,337.161,594,762,062.841,306,418,218.01986,181,555.46
筹资活动现金流出小计320,043,119.311,002,293,336.34776,524,106.49560,829,907.45
筹资活动产生的现金流量净额54,066,217.85592,468,726.5529,894,111.52425,351,648.01
汇率变动对现金及现金等价物的影响-269,396.66-340,194.21160,194.55221,602.02
现金及现金等价物净增加额-85,071,443.9891,657,436.8164,412,768.2961,485,951.75
期末现金及现金等价物余额193,279,878.07278,351,322.05251,106,653.53248,179,836.99
补充资料:
现金及现金等价物的净增加额-91,657,436.81-61,485,951.75
TOP↑